NCT04750928 2026-04-01
Cyclin-Dependent Kinase (CDK)4/6 Inhibitor Abemaciclib for Neurofibromatosis Type I (NF1) Related Atypical Neurofibromas
National Institutes of Health Clinical Center (CC)
Phase 1/2 Recruiting
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)